Exploratory IND Is Planned Using GB Sciences’ Proprietary Mixtures of Botanical Compounds to …

GB Sciences Is Seeking Partners to Supply Minor Cannabinoids for Parkinson’s Disease Clinical Trial. LAS VEGAS, April 17, 2018 /PRNewswire/ — GB Sciences, Inc. (OTCQB: GBLX), as previously reported, plans to file an Exploratory IND and perform a Phase 0 Clinical Trial to gather valuable …

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *